Back to User profile » Dr Shoko Tsuchimine
Papers published by Dr Shoko Tsuchimine:
A positive correlation between serum amyloid β levels and depressive symptoms among community-dwelling elderly individuals in Japan
Tsuruga K, Sugawara N, Yasui-Furukori N, Takahashi I, Tsuchimine S, Kaneda A, Nakaji S, Nakamura K
Neuropsychiatric Disease and Treatment 2014, 10:1621-1627
Published Date: 30 August 2014
Sex differences in the prediction of the effectiveness of paroxetine for patients with major depressive disorder identified using a receiver operating characteristic curve analysis for early response [Corrigendum]
Tomita T, Norio YF, Sato Y, Nakagami T, Tsuchimine S, Kaneda A, Kaneko S
Neuropsychiatric Disease and Treatment 2014, 10:997-998
Published Date: 5 June 2014
Possible impact of the CYP2D6*10 polymorphism on the nonlinear pharmacokinetic parameter estimates of paroxetine in Japanese patients with major depressive disorders
Saruwatari J, Nakashima H, Tsuchimine S, Nishimura M, Ogusu N, Yasui-Furukori N
Pharmacogenomics and Personalized Medicine 2014, 7:121-127
Published Date: 28 April 2014
Sex differences in the prediction of the effectiveness of paroxetine for patients with major depressive disorder identified using a receiver operating characteristic curve analysis for early response
Tomita T, Norio YF, Sato Y, Nakagami T, Tsuchimine S, Kaneda A, Kaneko S
Neuropsychiatric Disease and Treatment 2014, 10:599-606
Published Date: 8 April 2014
Possible associations between antioxidant enzyme polymorphisms and metabolic abnormalities in patients with schizophrenia
Saruwatari J, Yasui-Furukori N, Kamihashi R, Yoshimori Y, Oniki K, Tsuchimine S, Noai M, Sato Y, Nakagami T, Sugawara N, Saito M, Fujii A, Kajiwara A, Mihara S, Ogata Y, Kaneko S, Nakagawa K
Neuropsychiatric Disease and Treatment 2013, 9:1683-1698
Published Date: 1 November 2013